Longview Acquisition II Price to Free Cash Flow Ratio 2021-2022 | LGV

Longview Acquisition II price to free cash flow ratio from 2021 to 2022. Price to free cash flow ratio can be defined as

Longview Acquisition II Price to Free Cash Flow Ratio 2021-2022 | LGV

Longview Acquisition II price to free cash flow ratio from 2021 to 2022. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$212.5B
Intuitive Surgical (ISRG)$180.7B
Alcon (ALC)$45.5B
Edwards Lifesciences (EW)$40B
IQVIA Holdings (IQV)$38.1B
IDEXX Laboratories (IDXX)$33.9B
DexCom (DXCM)$27.2B
Waters (WAT)$23B
STERIS (STE)$22.3B
SONOVA HOLDING (SONVY)$22B
Hologic (HOLX)$19.4B
Fresenius Medical Care AG KGaA (FMS)$11.8B
Sysmex ADR (SSMXY)$11.6B
Globus Medical (GMED)$10.1B
Teleflex (TFX)$9.6B
Penumbra (PEN)$8.8B
Masimo (MASI)$7.8B
Glaukos (GKOS)$7.2B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.2B
Inari Medical (NARI)$2.9B
TransMedics (TMDX)$2.9B
Veracyte (VCYT)$2.7B
LivaNova (LIVN)$2.7B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.2B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.9B
Alphatec Holdings (ATEC)$1.2B